Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia

Molecular Medicine

Volumn 19, Issue 1, 2013, Pages 115-123

  Papakonstantinou, Nikos ^a,b,c   Ntoufa, Stavroula ^b,c   Chartomatsidou, Elisavet ^b,c   Papadopoulos, Giorgio ^d   Hatzigeorgiou, Artemis ^d   Anagnostopoulos, Achiles ^b   Chlichlia, Katerina ^a   Ghia, Paolo ^e   Muzio, Marta ^f   Belessi, Chrysoula ^g   Stamatopoulos, Kostas ^b,c  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

^c INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^d BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g Nikea General Hospital Athens   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; MICRORNA; MICRORNA 101; MICRORNA 15A; MICRORNA 29; MICRORNA 29B; MICRORNA 29C; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; IGHV1 GENE; IMMUNOGLOBULIN HEAVY CHAIN GENE; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; WESTERN BLOTTING;

FEMALE; HUMANS; IMMUNOGENETIC PHENOMENA; IMMUNOGLOBULINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MICRORNAS; POLYCOMB REPRESSIVE COMPLEX 2; RECEPTORS, ANTIGEN, B-CELL; RNA, MESSENGER;

EID: 84878175760     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2013.00005     Document Type: Article

References (52)

1. Rozman C, Montserrat E. (1995) Chronic lymphocytic leukemia. N. Engl. J. Med. 333:1052-1057
2. Ghia P, Chiorazzi N, Stamatopoulos K. (2008) Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J. Intern. Med. 264:549-562
3. Fais F, et al. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J. Clin. Invest. 102:1515-1525
4. Damle RN, et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 94:1840-1847
5. Hamblin TJ, et al. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 94:1848-1854
6. Agathangelidis A, et al. (2012) Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood. 119:4467-4475
7. Messmer BT, et al. (2004) Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J. Exp. Med. 200:519-525
8. Stamatopoulos K, et al. (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood. 109:259-270
9. Chiorazzi N, Ferrarini M. (2011) Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood. 117:1781-1791
10. Bourke E, et al. (2003) The Toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood. 102:956-963
11. Akira S, Takeda K, Kaisho T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680
12. Rawlings DJ, Schwartz MA, Jackson SW, Meyer- Bahlburg A. (2012) Integration of B cell responses through Toll-like receptors and antigen receptors. Nat. Rev. Immunol. 12:282-294
13. Lau CM, et al. (2005) RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202:1171-1177
14. Arvaniti E, et al. (2011) Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients. Haematologica. 96:1644-1652
15. Ntoufa S, et al. (2012) Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors. Mol. Med. 18:1281-1291
16. Longo PG, et al. (2007) The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia. 21:110-120
17. Bartel DP. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281-297
18. Huntzinger E, Izaurralde E. (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 12:99-110
19. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. (2011) Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10:111-122
20. O'Neill LA, Sheedy FJ, McCoy CE. (2011) MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat. Rev. Immunol. 11:163-175
21. Iorio MV, Piovan C, Croce CM. (2010) Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim. Biophys. Acta. 1799:694-701
22. Calin GA, et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 99:15524-15529
23. Calin GA, et al. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U. S. A. 101:11755-11760
24. Fulci V, et al. (2007) Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood. 109:4944-4951
25. Marton S, et al. (2008) Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia. 22:330-338
26. Pallasch CP, et al. (2009) miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood. 114:3255-3264
27. Stamatopoulos B, et al. (2009) microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood. 113:5237-5245
28. Calin GA, et al. (2005) A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353:1793-1801
29. Rossi S, et al. (2010) microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood. 116:945-952
30. Ferracin M, et al. (2010) MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. Mol. Cancer. 9:123
31. Moussay E, et al. (2010) Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia. Mol. Cancer. 9:115
32. Frenquelli M, et al. (2010) MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27. Blood. 115:3949-3959
33. Wang M, et al. (2008) miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol 215:13-20
34. Hallek M, et al. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 111:5446-5456
35. Akao Y, et al. (2007) Downregulation of microRNAs- 143 and -145 in B-cell malignancies. Cancer Sci. 98:1914-1920
36. Stevenson FK, et al. (2011) B-cell receptor signaling in chronic lymphocytic leukemia. Blood. 118:4313-4320
37. Li S, et al. (2009) MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology. 49:1194-1202
38. Wang HJ, et al. (2010) MicroRNA-101 is downregulated in gastric cancer and involved in cell migration and invasion. Eur. J. Cancer. 46:2295-2303
39. Morin RD, et al. (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet. 42:181-185
40. Varambally S, et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science. 322:1695-1699
41. Ryan RJ, et al. (2011) EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas. PLoS One. 6:e28585
42. Cao P, et al. (2010) MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol. Cancer. 9:108
43. Muzio M, et al. (2008) Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood. 112:188-195
44. Bomben R, et al. (2012) The miR-17~92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes. Leukemia. 26:1584-1593
45. Kluiver JL, Chen CZ. (2012) MicroRNAs regulate B-cell receptor signaling-induced apoptosis. Genes Immun. 13:239-244
46. Smonskey MT, et al. (2012) Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection. Am. J. Clin. Pathol. 137:641-646
47. Kostareli E, Gounari M, Agathangelidis A, Stamatopoulos K. (2012) Immunoglobulin gene repertoire in chronic lymphocytic leukemia: insight into antigen selection and microenvironmental interactions. Mediterr. J. Hematol. Infect. Dis. 4:e2012052
48. Simon JA, Lange CA. (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat. Res. 647:21-29
49. Tsang DP, Cheng AS. (2011) Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. J. Gastroenterol. Hepatol. 26:19-27
50. Guo H, Ingolia NT, Weissman JS, Bartel DP. (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 466:835-840
51. Baek D, et al. (2008) The impact of microRNAs on protein output. Nature. 455:64-71
52. Ntoufa S. (2012) The miR-17~92 cluster is an immunomodulator in CLL regulating distinct functional responses to Toll-like receptors in subsets with stereotyped antigen receptors. Blood (ASH Annual Meeting Abstracts). 120:3862.